Literature DB >> 8386191

Crystal-induced neutrophil activation. III. Inflammatory microcrystals induce a distinct pattern of tyrosine phosphorylation in human neutrophils.

M Gaudry1, C J Roberge, R de Médicis, A Lussier, P E Poubelle, P H Naccache.   

Abstract

The activation of human neutrophils by monosodium urate and calcium pyrophosphate dihydrate crystals is believed to play a critical role in the pathogenesis of arthritides such as acute gout and pseudogout, respectively. In this study, we investigated the potential involvement of tyrosine phosphorylation in microcrystal-mediated activation of human neutrophils. Immunoblot analysis with antiphosphotyrosine antibodies demonstrated that triclinic monosodium urate and calcium pyrophosphate dihydrate crystals stimulated a time- and concentration-dependent tyrosine phosphorylation of at least five proteins (pp130, 118, 80, 70, and 60). While phosphoprotein (pp) 118 and pp70 were the major phosphorylated substrates, pp70 was the dominant one in reactivity with antiphosphotyrosine antibodies. When the temporal patterns, as well as the levels of tyrosine phosphorylation for both types of crystals were compared, monosodium urate crystals were found to be more potent activators than calcium pyrophosphate dihydrate crystals. The tyrosine phosphorylation patterns induced by microcrystals differed from those stimulated by other soluble (FMLP, C5a, or leukotriene B4) or particulate (unopsonized latex beads or zymosan) agonists which stimulated preferentially the tyrosine phosphorylation of pp118. The ratio of the intensities of pp118 and pp70 were specific of the stimulation with microcrystals when compared to those observed with the other soluble or particulate agonists. Colchicine, a drug used specifically in the treatment of gout and pseudogout, inhibited microcrystal-induced tyrosine phosphorylation, while beta- and gamma-lumicolchicine were without effect. On the other hand, colchicine failed to inhibit FMLP-induced tyrosine phosphorylation. Furthermore, while colchicine inhibited the activation of the NADPH oxidase by microcrystals, it, on the other hand, enhanced the production of superoxide anions by FMLP. Taken together, these results (a) demonstrate that tyrosine phosphorylation is involved in the mechanism of activation of human neutrophils induced by microcrystals; and (b) suggest, on the basis of the characteristics of the observed patterns of tyrosine phosphorylation, that this response may be specific to the microcrystals and relevant to their phlogistic properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386191      PMCID: PMC288143          DOI: 10.1172/JCI116373

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Monosodium urate crystals stimulate phospholipase A2 enzyme activities and the synthesis of a phospholipase A2-activating protein.

Authors:  J S Bomalaski; D G Baker; L M Brophy; M A Clark
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

2.  Inflammatory reactions induced by various calcium pyrophosphate crystals.

Authors:  M Roch-Arveiller; R Legros; B Chanaud; O Muntaner; S Strzalko; A Thuret; D A Willoughby; J P Giroud
Journal:  Biomed Pharmacother       Date:  1990       Impact factor: 6.529

3.  Mechanism of neutrophil activation by an unopsonized inflammatory particulate. Monosodium urate crystals induce pertussis toxin-insensitive hydrolysis of phosphatidylinositol 4,5-bisphosphate.

Authors:  E Onello; A Traynor-Kaplan; L Sklar; R Terkeltaub
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

Review 4.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

5.  Crystal-induced neutrophil activation. I. Initiation and modulation of calcium mobilization and superoxide production by microcrystals.

Authors:  P H Naccache; M Grimard; C J Roberge; C Gilbert; A Lussier; R de Médicis; P E Poubelle
Journal:  Arthritis Rheum       Date:  1991-03

6.  Neutrophil activation by inflammatory microcrystals of monosodium urate monohydrate utilizes pertussis toxin-insensitive and -sensitive pathways.

Authors:  R A Terkeltaub; L A Sklar; H Mueller
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

7.  Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation.

Authors:  R Terkeltaub; C Zachariae; D Santoro; J Martin; P Peveri; K Matsushima
Journal:  Arthritis Rheum       Date:  1991-07

8.  A comparison of the effects of urate, hydroxyapatite and diamond crystals on polymorphonuclear cells: relationship of mediator release to the surface area and adsorptive capacity of different particles.

Authors:  A Swan; B Dularay; P Dieppe
Journal:  J Rheumatol       Date:  1990-10       Impact factor: 4.666

9.  Platelet-activating factor induces tyrosine phosphorylation in human neutrophils.

Authors:  J Gomez-Cambronero; E Wang; G Johnson; C K Huang; R I Sha'afi
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

10.  Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2.

Authors:  J D Sharp; D L White; X G Chiou; T Goodson; G C Gamboa; D McClure; S Burgett; J Hoskins; P L Skatrud; J R Sportsman
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

View more
  17 in total

1.  Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol.

Authors:  J K Jackson; C Tudan; B Sahl; S L Pelech; H M Burt
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

2.  Gout: questions that still need to be answered.

Authors:  R A Terkeltaub
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

3.  Inflammatory gout: observations over a half-century.

Authors:  Stephen E Malawista; Anne Chevance de Boisfleury; Paul H Naccache
Journal:  FASEB J       Date:  2011-12       Impact factor: 5.191

4.  Activation of S6 kinase in human neutrophils by calcium pyrophosphate dihydrate crystals: protein kinase C-dependent and phosphatidylinositol-3-kinase-independent pathways.

Authors:  C Tudan; J K Jackson; L Charlton; S L Pelech; B Sahl; H M Burt
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

5.  Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action.

Authors:  C Marques-da-Silva; M M Chaves; N G Castro; R Coutinho-Silva; M Z P Guimaraes
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils.

Authors:  B N Cronstein; Y Molad; J Reibman; E Balakhane; R I Levin; G Weissmann
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

7.  Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine.

Authors:  C J Roberge; M Gaudry; R de Médicis; A Lussier; P E Poubelle; P H Naccache
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Tyrosine phosphorylation and activation of NADPH oxidase in human neutrophils: a possible role for MAP kinases and for a 75 kDa protein.

Authors:  S Dusi; M Donini; F Rossi
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

9.  Leukotriene synthesis in calcium-depleted human neutrophils: arachidonic acid release correlates with calcium influx.

Authors:  E Krump; M Pouliot; P H Naccache; P Borgeat
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

10.  Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine.

Authors:  E W Chia; R Grainger; J L Harper
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.